Athira Pharma, Inc.
ATHA
$0.295
-$0.008-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.06% | 47.80% | -7.01% | -1.98% | 3.47% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.41% | 0.00% | -1.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.73% | -22.99% | -5.10% | 25.11% | 23.79% |
| Change in Net Operating Assets | 45.24% | -633.46% | 113.30% | 154.35% | -74.32% |
| Cash from Operations | 43.62% | -12.99% | -3.10% | 13.46% | 1.86% |
| Capital Expenditure | -- | -- | 100.00% | -460.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -161.42% | -115.59% | -32.16% | 103.82% | 104.13% |
| Cash from Investing | -161.42% | -115.59% | -32.09% | 103.68% | 104.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 183.33% | -91.89% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 183.33% | -91.89% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.53% | -479.06% | -213.52% | 134.32% | 35.38% |